IMZYLGO
"IMZYLGO" is a word mark owned by Abivax, filed at the USPTO on October 14, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since October 14, 2026
- Filed
- October 14, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50161647
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns IMZYLGO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Abivax
Paris, France
Representative
Ronald M. Kachmarik
Cooper Legal Group, LLC
What the mark covers
The products and services IMZYLGO is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of inflammatory, immune-mediated or autoimmune diseases, disorders and conditions; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of inflammatory, immune-mediated or autoimmune diseases, disorders and conditions
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About IMZYLGO
Who owns the trademark "IMZYLGO"?
The USPTO trademark "IMZYLGO" (application 50161647) is owned by Abivax.
What is the status of "IMZYLGO"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull IMZYLGO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a13fa9-3e4a-72f1-8a58-e3025dcb646e
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a13fa9-3e4a-72f1-8a58-e3025dcb646e",
"object": "trademark",
"mark_text": "IMZYLGO",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50161647",
"filing_date": "2026-10-14",
"nice_classes": [
5
],
"owners": [
{
"name": "ABIVAX",
"entity_id": "ent_019eb714-68ff-751f-8022-30be9e3f38d3"
}
]
}